Taken together, we conclude that the anti-cancer effects of ERβ in TNBC are largely dependent on its ability to directly interact with DNA, and that failure to do so renders ERβ incapable of suppressing oncogenic NFκB signaling and functioning as a tumor suppressor. This evidence concerns the gene ESR2 and neoplasm.